Nock's charts and analysis are amazing and so far SPOT ON. can't wait to see this continue this upward trajectory into quarter land and beyond by year end (I wouldn't be surprised to see 25+ cents even sooner than year end).
GO RXMD!!!

BEST GEM IN THE OTC!!!!